People: Aastrom Biosciences Inc (ASTM.O)

ASTM.O on Consolidated Issue listed on NASDAQ Capital Market

3.27USD
28 Jul 2014
Price Change (% chg)

$0.03 (+0.93%)
Prev Close
$3.24
Open
$3.26
Day's High
$3.27
Day's Low
$3.20
Volume
49,600
Avg. Vol
207,230
52-wk High
$17.79
52-wk Low
$3.09

Search Stocks

Colangelo, Dominick 

Brief Biography

Mr. Dominick C. Colangelo is President, Chief Executive Officer, Chief Accounting Officer, Treasurer, Director of Aastrom Biosciences Inc. Mr. Colangelo joined Aastrom in 2013 with more than twenty years of executive management and corporate development experience in the biopharmaceutical industry, including nearly a decade with Eli Lilly and Company. Most recently, he was President and Chief Executive Officer of Promedior, Inc. During his career, he has held a variety of executive positions of increasing responsibility in product development, pharmaceutical operations, sales and marketing, and corporate development. He has experience in the acquisition, development and commercialization of therapies to treat fibrovascular, metabolic and cardiovascular diseases. During his tenure at Eli Lilly and Company, he held positions as Director of Strategy and Business Development for Lilly’s Diabetes Product Group and also served as a founding Managing Director of Lilly Ventures. Mr. Colangelo received his B.S.B.A. in Accounting, Magna Cum Laude, from the State University of New York at Buffalo and a J.D. degree, with Honors, from the Duke University School of Law.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
358,333 -- 1,086,730 1,445,060

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks